Literature DB >> 35382125

Clinical significance and usefulness of rehabilitation for systemic sclerosis.

Naoki Mugii1, Yasuhito Hamaguchi2, Susanna Maddali-Bongi3.   

Abstract

Systemic sclerosis is a multisystem connective tissue disorder characterized by excessive fibrosis of the skin and internal organs. Impairments in skin, the musculoskeletal system, and respiratory system require rehabilitation therapy because they may lead to disabilities and reduce the quality of life in daily activities. Rehabilitation for systemic sclerosis mainly comprises two distinct approaches that include local and global rehabilitation. Local rehabilitation is applied to maintain and/or improve hand and face functions, while global rehabilitation includes aerobic and resistance exercises. Although few high-quality randomized clinical trials have been conducted to date, previous studies indicated the effectiveness of rehabilitation therapy for decreasing local and systemic disabilities, resulting in improved quality of life. Rehabilitation for systemic sclerosis needs to be regularly and constantly performed at home as well as in hospitals. Physicians involved in the treatment of systemic sclerosis need to consider rehabilitation, and skilled physiotherapists and occupational therapists also play a crucial role in evaluating and treating systemic sclerosis patients.
© The Author(s) 2018.

Entities:  

Keywords:  Face disability; Hand disability; Occupational therapy; Physiotherapy; Rehabilitation; Systemic sclerosis

Year:  2018        PMID: 35382125      PMCID: PMC8892873          DOI: 10.1177/2397198317750043

Source DB:  PubMed          Journal:  J Scleroderma Relat Disord        ISSN: 2397-1983


  63 in total

1.  [Health related quality of life assessment in patients with systemic sclerosis].

Authors:  R Gualtierotti; L Scalone; F Ingegnoli; P Cortesi; C Lubatti; S Zeni; P L Meroni
Journal:  Reumatismo       Date:  2010 Jul-Sep

2.  Evaluation of health-related quality-of-life and dyspnea scales in patients with idiopathic pulmonary fibrosis. Correlation with pulmonary function tests.

Authors:  Nikolaos Tzanakis; Maria Samiou; Irini Lambiri; Katerina Antoniou; Nikolaos Siafakas; Demosthenes Bouros
Journal:  Eur J Intern Med       Date:  2005-04       Impact factor: 4.487

3.  Exercise training in patients with pulmonary arterial hypertension: a case report.

Authors:  Michael J Shoemaker; Jeffrey L Wilt; Rajkumar Dasgupta; Ronald J Oudiz
Journal:  Cardiopulm Phys Ther J       Date:  2009-12

Review 4.  Aerobic and resistance exercise in systemic sclerosis: State of the art.

Authors:  Natália Cristina de Oliveira; Leslie Andrews Portes; Henrik Pettersson; Helene Alexanderson; Carina Boström
Journal:  Musculoskeletal Care       Date:  2017-04-05

5.  Evaluation of the chronic obstructive pulmonary disease assessment test for measurement of health-related quality of life in patients with interstitial lung disease.

Authors:  Kazuma Nagata; Keisuke Tomii; Kojiro Otsuka; Ryo Tachikawa; Kyoko Otsuka; Junpei Takeshita; Kosuke Tanaka; Takeshi Matsumoto; Kazuya Monden
Journal:  Respirology       Date:  2012-04       Impact factor: 6.424

6.  Effects of a nonsurgical exercise program on the decreased mouth opening in patients with systemic scleroderma.

Authors:  G Pizzo; G A Scardina; P Messina
Journal:  Clin Oral Investig       Date:  2003-07-09       Impact factor: 3.573

7.  European League Against Rheumatism (EULAR) Scleroderma Trial and Research group (EUSTAR) recommendations for the treatment of systemic sclerosis: methods of elaboration and results of systematic literature research.

Authors:  J Avouac; O Kowal-Bielecka; R Landewe; S Chwiesko; I Miniati; L Czirjak; P Clements; C Denton; D Farge; K Fligelstone; I Földvari; D E Furst; U Müller-Ladner; J Seibold; R M Silver; K Takehara; B Garay Toth; A Tyndall; G Valentini; F van den Hoogen; F Wigley; F Zulian; M Matucci-Cerinic
Journal:  Ann Rheum Dis       Date:  2008-10-28       Impact factor: 19.103

Review 8.  Musculoskeletal rehabilitation in the person with scleroderma.

Authors:  Janet L Poole
Journal:  Curr Opin Rheumatol       Date:  2010-03       Impact factor: 5.006

9.  Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia.

Authors:  Vibha N Lama; Kevin R Flaherty; Galen B Toews; Thomas V Colby; William D Travis; Qi Long; Susan Murray; Ella A Kazerooni; Barry H Gross; Joseph P Lynch; Fernando J Martinez
Journal:  Am J Respir Crit Care Med       Date:  2003-08-13       Impact factor: 21.405

10.  The nonsurgical treatment of microstomia in scleroderma: a pilot study.

Authors:  W P Naylor; C W Douglass; E Mix
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1984-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.